Comparison of Efficacies of Cysteine Protease Inhibitors against Five Strains of Plasmodium falciparum

AUTOR(ES)

Singh, Ajay

FONTE

American Society for Microbiology

RESUMO

Falcipain-2, a cysteine protease and essential hemoglobinase of Plasmodium falciparum, is a potential antimalarial drug target. We compared the falcipain-2 sequences and sensitivities to cysteine protease inhibitors of five parasite strains that differ markedly in sensitivity to established antimalarial drugs. The sequence of falcipain-2 was highly conserved, and the sensitivities of all of the strains to falcipain-2 inhibitors were very similar. Thus, cross-resistance between cysteine protease inhibitors and other antimalarial agents is not expected in parasites that are now circulating and falcipain-2 remains a promising chemotherapeutic target.

Documentos Relacionados

• Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.
• Role of Plasmodium falciparum Digestive Vacuole Plasmepsins in the Specificity and Antimalarial Mode of Action of Cysteine and Aspartic Protease Inhibitors ▿ †
• Alternative Oxidase Inhibitors Potentiate the Activity of Atovaquone against Plasmodium falciparum
• Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites
• Structure-Activity Relationships for Inhibition of Cysteine Protease Activity and Development of Plasmodium falciparum by Peptidyl Vinyl Sulfones